Moderna
MRNA
#1638
Rank
S$16.41 B
Marketcap
S$42.01
Share price
1.42%
Change (1 day)
-23.58%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$16.41 Billion

As of December 2025 Moderna has a market cap of S$16.41 Billion. This makes Moderna the world's 1638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025S$16.41 B-21.79%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Dec 24th, 2025 the market cap of Moderna was reported to be:

S$16.18 Billion
by Nasdaq info icon info icon
S$16.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
S$0.72 B-95.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$341.09 B 1,977.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.06 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$67.90 B 313.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$341.85 B 1,982.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
S$12.43 B-24.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$642.19 B 3,812.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.81 B-76.73%๐Ÿ‡บ๐Ÿ‡ธ USA